Current Neuropharmacology
Title: Preface (New Research Frontiers and Advances in Drug Addiction)
Volume: 9 Issue: 1
Author(s): Syed F. Ali, Emmanuel Onaivi, Hyoung-Chun Kim, Michael J. Kuhar and George Koob
Affiliation:
Export Options
About this article
Cite this article as:
F. Ali Syed, Onaivi Emmanuel, Kim Hyoung-Chun, J. Kuhar Michael and Koob George, Preface (New Research Frontiers and Advances in Drug Addiction), Current Neuropharmacology 2011; 9 (1) . https://dx.doi.org/10.2174/157015911795017272
DOI https://dx.doi.org/10.2174/157015911795017272 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Non-canonical Molecular Targets for Novel Analgesics: Intracellular Calcium and HCN Channels
Current Neuropharmacology Resveratrol as a Potential Therapeutic Candidate for the Treatment and Management of Alzheimer's Disease
Current Topics in Medicinal Chemistry A Case of Toxic Epidermal Necrolysis Secondary to Acetaminophen in a Child
Current Drug Safety Melatonin in Autism Spectrum Disorders
Current Clinical Pharmacology Important Hints in Behavioural Teratology of Rodents
Current Pharmaceutical Design TRYCAT Pathways Link Peripheral Inflammation, Nicotine, Somatization and Depression in the Etiology and Course of Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Vascular Dementia: Atherosclerosis, Cognition and Alzheimers Disease
Current Alzheimer Research Brain Structural Abnormalities at the Onset of Schizophrenia and Bipolar Disorder: A Meta-analysis of Controlled Magnetic Resonance Imaging Studies
Current Pharmaceutical Design Role of NLRP-3 Inflammasome in Hypertension: A Potential Therapeutic Target
Current Pharmaceutical Biotechnology New Pharmacological Approaches to the Prevention of Myocardial Ischemia- Reperfusion Injury
Current Drug Targets Peroxisome Proliferator-Activated Receptor (PPAR) Agonists as Promising New Medications for Drug Addiction: Preclinical Evidence
Current Drug Targets Microglial Cathepsin B and <i>Porphyromonas gingivalis</i> Gingipains as Potential Therapeutic Targets for Sporadic Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets Neuroimaging of Consciousness and Sleep Spindles
Recent Patents on Medical Imaging SiRNA Nanotherapeutics _The Panacea of Diseases?
Current Gene Therapy Cancer-Related Fatigue: Still an Enigma to be Solved Quickly
Reviews on Recent Clinical Trials Brain Peptides for the Treatment of Neuropsychiatric Disorders
Current Pharmaceutical Design Understanding the Use of Immunosuppressive Agents in the Clinical Management of IBD
Current Drug Targets Central Nervous System Depressants and Risk of Hospitalization due to Community-Acquired Pneumonia in very Old Patients
Current Drug Safety Overcoming Treatment Barriers in Adolescent Psychiatry
Adolescent Psychiatry The 18-kDa Translocator Protein as a CNS Drug Target: Finding Our Way Through the Neuroinflammation Fog
CNS & Neurological Disorders - Drug Targets